Values of spleen-preserving distal pancreatectomy in well-differentiated non-functioning pancreatic neuroendocrine tumors: a comparative study

被引:2
|
作者
Huang, Xi-Tai [1 ]
Xie, Jin-Zhao [1 ]
Cai, Jian-Peng [1 ]
Fang, Peng [1 ]
Huang, Chen-Song [1 ]
Chen, Wei [1 ]
Liang, Li-Jian [1 ]
Yin, Xiao-Yu [1 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pancreatobiliary Surg, 58 Zhongshan 2nd Rd, Guangzhou 510080, Guangdong, Peoples R China
来源
GASTROENTEROLOGY REPORT | 2022年 / 10卷
关键词
pancreatic neuroendocrine tumor; distal pancreatectomy; spleen preservation; prognosis; POSTOPERATIVE OUTCOMES; UPDATE; COMPLICATIONS; PRESERVATION; SPLENECTOMY;
D O I
10.1093/gastro/goac056
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background The feasibility of spleen-preserving distal pancreatectomy (SPDP) to treat well-differentiated non-functioning pancreatic neuroendocrine tumors (NF-pNETs) located at the body and/or tail of the pancreas remains controversial. Distal pancreatectomy with splenectomy (DPS) has been widely applied in the treatment of NF-pNETs; however, it may increase the post-operative morbidities. This study aimed to evaluate whether SPDP is inferior to DPS in post-operative outcomes and survivals when being used to treat patients with NF-pNETs in our institute. Methods Clinicopathological features of patients with NF-pNETs who underwent curative SPDP or DPS at the First Affiliated Hospital of Sun Yat-sen University (Guangzhou, China) between January 2010 and January 2022 were collected. Short-term outcomes and 5-year survivals were compared between patients undergoing SPDP and those undergoing DPS. Results Sixty-three patients (SPDP, 27; DPS, 36) with well-differentiated NF-pNETs were enrolled. All patients had grade 1/2 tumors. After identifying patients with T1-T2 NF-pNETs (SPDP, 27; DPS, 15), there was no disparity between the SPDP and DPS groups except for tumor size (median, 1.4 vs 2.6 cm, P = 0.001). There were no differences in operation time (median, 250 vs 295 min, P = 0.478), intraoperative blood loss (median, 50 vs 100 mL, P = 0.145), post-operative major complications (3.7% vs 13.3%, P = 0.287), clinically relevant post-operative pancreatic fistula (22.2% vs 6.7%, P = 0.390), or post-operative hospital stays (median, 9 vs 9 days, P = 0.750) between the SPDP and DPS groups. Kaplan-Meier curve showed no significant differences in the 5-year overall survival rate (100% vs 100%, log-rank P > 0.999) or recurrence-free survival (100% vs 100%, log-rank P > 0.999) between patients with T1-T2 NF-pNETs undergoing SPDP and those undergoing DPS. Conclusions In patients with T1-T2 well-differentiated NF-pNETs, SPDP could achieve comparable post-operative outcomes and prognosis compared with DPS.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] Comparison of Methods for Grading Gastrointestinal and Pancreatic Well-Differentiated Neuroendocrine Tumors
    Goodell, Pamela P.
    Krasinskas, Alyssa M.
    Hartman, Douglas J.
    GASTROENTEROLOGY, 2011, 140 (05) : S875 - S875
  • [42] Well-Differentiated Pancreatic Neuroendocrine Tumors: Prognostic Significance of Pathological Parameters
    Perez-Casanova, L.
    Serrano, T.
    Navas, C.
    Ruiz, N.
    Gomez, A.
    Loayza, C.
    Nienow, C.
    Salazar, R.
    Villabona, C.
    Valls, C.
    Fabregat, J.
    Condom, E.
    NEUROENDOCRINOLOGY, 2014, 99 (3-4) : 250 - 250
  • [43] Recurrence After Curative Resection for Well-Differentiated Pancreatic Neuroendocrine Tumors
    Kimura, H.
    Ohtsuka, T.
    Date, K.
    Fujimoto, T.
    Matsunaga, T.
    Watanabe, Y.
    Tamura, K.
    Miyasaka, Y.
    Yamada, D.
    Takahata, S.
    Igarashi, H.
    Ito, T.
    Oda, Y.
    Tanaka, M.
    PANCREAS, 2014, 43 (08) : 1379 - 1379
  • [44] Spleen-preserving distal pancreatectomy following grade III pancreatic injury in a delayed presentation: a technical challenge
    Mulpuri, Venu Bhargava
    Bhuria, Dinesh Kumar
    Rana, Surinder
    Gupta, Rajesh
    BMJ CASE REPORTS, 2021, 14 (06)
  • [45] PAX8 expression reliably distinguishes pancreatic well-differentiated neuroendocrine tumors from Heal and pulmonary well-differentiated neuroendocrine tumors and pancreatic acinar cell carcinoma
    Sangoi, Ankur R.
    Ohgami, Robert S.
    Pai, Rish K.
    Beck, Andrew H.
    McKenney, Jesse K.
    Pai, Reetesh K.
    MODERN PATHOLOGY, 2011, 24 (03) : 412 - 424
  • [46] Successful treatment of pancreatic accessory splenic hamartoma by laparoscopic spleen-preserving distal pancreatectomy: A case report
    Shao-Yan Xu
    Bo Zhou
    Shu-Mei Wei
    Ya-Nan Zhao
    Sheng Yan
    World Journal of Gastrointestinal Oncology, 2022, 14 (05) : 1057 - 1064
  • [47] Simultaneous laparoscopic left hemicolectomy and spleen-preserving distal pancreatectomy for descending colon cancer with pancreatic invasion
    Nagasaki, Toshiya
    Mise, Yoshihiro
    Honma, Satoru
    Sato, Takafumi
    Akiyoshi, Takashi
    Fukunaga, Yosuke
    Tominaga, Tetsuro
    Nagaoka, Tomoyuki
    Yamaguchi, Tomohiro
    Ueno, Masashi
    ASIAN JOURNAL OF ENDOSCOPIC SURGERY, 2019, 12 (03) : 334 - 336
  • [48] Successful treatment of pancreatic accessory splenic hamartoma by laparoscopic spleen-preserving distal pancreatectomy: A case report
    Xu, Shao-Yan
    Zhou, Bo
    Wei, Shu-Mei
    Zhao, Ya-Nan
    Yan, Sheng
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022, 14 (05) : 1057 - 1064
  • [49] Non-functioning pancreatic neuroendocrine tumors - A case report and review of literature
    Rampurwala M.M.
    Kumar A.
    Kannan S.
    Kowalczyk P.
    Khera S.
    Journal of Gastrointestinal Cancer, 2011, 42 (4) : 257 - 262
  • [50] Reconsidering Lymphadenectomy for Locoregional Resectable Non-Functioning Pancreatic Neuroendocrine Tumors
    de Geus, S. W. L.
    Kasumova, G. G.
    Ng, S. C.
    Kent, T. S.
    McAneny, D.
    Kulke, M. H.
    Tseng, J. F.
    Sachs, T. E.
    PANCREAS, 2018, 47 (10) : 1382 - 1382